首页> 外国专利> Thrombolytic agent containing plasmin and a plasminogen activator.

Thrombolytic agent containing plasmin and a plasminogen activator.

机译:包含纤溶酶和纤溶酶原激活剂的溶栓剂。

摘要

Claimed is a pharmaceutical compsn. having a thrombolytic effect and contg. plasmin and a plasminogen activator, at least partially in a free form (not as complex with plasmin and/or plasminogen), opt. with common pharmaceutical additives or carriers. Pref. the plasminogen activator is at least 30%, pref. 50% in a free form and the plasmin is fibrinolytically active. Also claimed is a prodn. method for the inventive compsn. by mixing plasminogen and/or plasmin with a plasminogen activator for the prodn. of plasmin. Pref. compsns. are used including plasminogens inactivated by virus. The plasmin pref. is produced in vitro from a plasminogen, (e.g. Lys-plasminogen) and a plasminogen activator. A treatment for thrombosis in mammals applying the claimed compsn. of plasmin, plasminogen activator and opt. plasminogens systemically or at the place of thrombosis is also claimed.
机译:声称是制药公司。具有溶栓作用和持续作用。纤溶酶和纤溶酶原激活剂,至少部分呈游离形式(不与纤溶酶和/或纤溶酶原复合)。与常见的药物添加剂或载体一起使用。首选纤溶酶原激活剂的含量至少为30%。 50%为游离形式,纤溶酶具有纤溶活性。还声称是产品。本发明组合物的方法。通过将纤溶酶原和/或纤溶酶与产品的纤溶酶原激活剂混合纤溶酶。首选compsns。包括被病毒灭活的纤溶酶原。纤溶酶偏爱。由纤溶酶原(例如Lys-纤溶酶原)和纤溶酶原激活剂体外产生。应用所要求保护的化合物的哺乳动物血栓形成治疗。纤溶酶,纤溶酶原激活剂和选择。还要求保护全身或在血栓形成部位的纤溶酶原。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号